These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 1606913
1. Serum intact parathyroid hormone concentration measured by a two-site immunoradiometric assay in normal subjects and patients with various parathyroid disorders. Okazaki R, Matsumoto T, Furukawa Y, Fujimoto Y, Niimi H, Seino Y, Fujita T, Nagataki S, Ogata E. Endocrinol Jpn; 1992 Feb; 39(1):115-20. PubMed ID: 1606913 [Abstract] [Full Text] [Related]
4. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract. Werder EA, Fischer JA, Illig R, Kind HP, Bernasconi S, Fanconi A, Prader A. J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700 [Abstract] [Full Text] [Related]
5. Ratio of baseline level/maximum level of serum PTH in pseudohypoparathyroidism and primary hyperparathyroidism. Mizunashi K, Furukawa Y, Goto MM. Calcif Tissue Int; 1998 Feb; 62(2):99-103. PubMed ID: 9437041 [Abstract] [Full Text] [Related]
8. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. Gao P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt-Gayk H, Cantor TL. J Bone Miner Res; 2001 Apr; 16(4):605-14. PubMed ID: 11315988 [Abstract] [Full Text] [Related]
9. Two-site assay of intact parathyroid hormone in primary hyperparathyroidism: studies in basal conditions, following adenoma removal and during calcium and EDTA infusion. Mazzuoli G, Minisola S, Scarnecchia L, Pacitti MT, Carnevale V, Romagnoli E, Bigi F, Bianchi G. Clin Chim Acta; 1990 Oct 15; 190(3):239-48. PubMed ID: 2123754 [Abstract] [Full Text] [Related]
12. Conventional and new diagnostic applications of a two-site immunochemiluminometric assay for parathyroid hormone. Minisola S, Scarnecchia L, Romagnoli E, Carnevale V, Pacitti MT, Scarda A, Rosso R, Mazzuoli GF. J Endocrinol Invest; 1992 Oct 15; 15(7):483-9. PubMed ID: 1447486 [Abstract] [Full Text] [Related]
13. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism. Silverberg SJ, Gao P, Brown I, LoGerfo P, Cantor TL, Bilezikian JP. J Clin Endocrinol Metab; 2003 Oct 15; 88(10):4725-30. PubMed ID: 14557447 [Abstract] [Full Text] [Related]
14. The modulatory effect of endogenous parathyroid hormone on the action of hydrochlorothiazide in pseudohypoparathyroidism type I. Mizunashi K, Furukawa Y, Abe K, Yoshinaga K. Calcif Tissue Int; 1994 Jun 15; 54(6):473-6. PubMed ID: 8082049 [Abstract] [Full Text] [Related]
15. An investigation of the biological activity of parathyroid hormone in pseudohypoparathyroidism: comparison with vitamin D deficiency. Allgrove J, Chayen J, Jayaweera P, O'Riordan JL. Clin Endocrinol (Oxf); 1984 May 15; 20(5):503-14. PubMed ID: 6744632 [Abstract] [Full Text] [Related]
18. Sigmoidal curve shift in idiopathic hypoparathyroidism and pseudohypoparathyroidism. Mizunashi K, Furukawa Y, Goto MM, Abe K. Calcif Tissue Int; 1998 Apr 15; 62(4):290-4. PubMed ID: 9504951 [Abstract] [Full Text] [Related]
19. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients. Morita A, Tabata T, Koyama H, Emoto M, Inoue T, Miki T, Nishizawa Y, Morii H. Clin Nephrol; 1992 Sep 15; 38(3):154-7. PubMed ID: 1395169 [Abstract] [Full Text] [Related]